These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 31363385)

  • 21. Epigenetics and Type 2 Diabetes Risk.
    Dhawan S; Natarajan R
    Curr Diab Rep; 2019 Jun; 19(8):47. PubMed ID: 31250127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Translating exome sequencing from research to clinical diagnostics.
    Coonrod EM; Margraf RL; Voelkerding KV
    Clin Chem Lab Med; 2011 Dec; 50(7):1161-8. PubMed ID: 22850020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetics of Type 2 Diabetes: Past, Present, and Future.
    Laakso M; Fernandes Silva L
    Nutrients; 2022 Aug; 14(15):. PubMed ID: 35956377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current genetic diagnostics in inborn errors of immunity.
    von Hardenberg S; Klefenz I; Steinemann D; Di Donato N; Baumann U; Auber B; Klemann C
    Front Pediatr; 2024; 12():1279112. PubMed ID: 38659694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetics of type 2 diabetes.
    Ahlqvist E; Ahluwalia TS; Groop L
    Clin Chem; 2011 Feb; 57(2):241-54. PubMed ID: 21119033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetics and Genomics Approaches for Diagnosis and Research Into Hereditary Anemias.
    Russo R; Marra R; Rosato BE; Iolascon A; Andolfo I
    Front Physiol; 2020; 11():613559. PubMed ID: 33414725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human Genetics of Obesity and Type 2 Diabetes Mellitus: Past, Present, and Future.
    Ingelsson E; McCarthy MI
    Circ Genom Precis Med; 2018 Jun; 11(6):e002090. PubMed ID: 29899044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene-level analysis of rare variants in 379,066 whole exome sequences identifies an association of GIGYF1 loss of function with type 2 diabetes.
    Deaton AM; Parker MM; Ward LD; Flynn-Carroll AO; BonDurant L; Hinkle G; Akbari P; Lotta LA; ; ; Baras A; Nioi P
    Sci Rep; 2021 Nov; 11(1):21565. PubMed ID: 34732801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Whole-exome sequencing in maya indigenous families: variant in PPP1R3A is associated with type 2 diabetes.
    Sánchez-Pozos K; Ortíz-López MG; Peña-Espinoza BI; de Los Ángeles Granados-Silvestre M; Jiménez-Jacinto V; Verleyen J; Tekola-Ayele F; Sanchez-Flores A; Menjivar M
    Mol Genet Genomics; 2018 Oct; 293(5):1205-1216. PubMed ID: 29948331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Whole-genome re-sequencing for the identification of high contribution susceptibility gene variants in patients with type 2 diabetes.
    Sun X; Sui W; Wang X; Hou X; Ou M; Dai Y; Xiang Y
    Mol Med Rep; 2016 May; 13(5):3735-46. PubMed ID: 27035118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances in understanding the molecular genetic basis of mitochondrial disease.
    Thompson K; Collier JJ; Glasgow RIC; Robertson FM; Pyle A; Blakely EL; Alston CL; Oláhová M; McFarland R; Taylor RW
    J Inherit Metab Dis; 2020 Jan; 43(1):36-50. PubMed ID: 31021000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. (Epi)genomic heterogeneity of pancreatic islet function and failure in type 2 diabetes.
    Lawlor N; Stitzel ML
    Mol Metab; 2019 Sep; 27S(Suppl):S15-S24. PubMed ID: 31500827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GenePy - a score for estimating gene pathogenicity in individuals using next-generation sequencing data.
    Mossotto E; Ashton JJ; O'Gorman L; Pengelly RJ; Beattie RM; MacArthur BD; Ennis S
    BMC Bioinformatics; 2019 May; 20(1):254. PubMed ID: 31096927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genome-Wide Sequencing for Unexplained Developmental Disabilities or Multiple Congenital Anomalies: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2020; 20(11):1-178. PubMed ID: 32194879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of next-generation sequencing technologies in Neurology.
    Jiang T; Tan MS; Tan L; Yu JT
    Ann Transl Med; 2014 Dec; 2(12):125. PubMed ID: 25568878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic markers of type 2 diabetes: Progress in genome-wide association studies and clinical application for risk prediction.
    Wang X; Strizich G; Hu Y; Wang T; Kaplan RC; Qi Q
    J Diabetes; 2016 Jan; 8(1):24-35. PubMed ID: 26119161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The emerging genetics of type 2 diabetes.
    Bonnefond A; Froguel P; Vaxillaire M
    Trends Mol Med; 2010 Sep; 16(9):407-16. PubMed ID: 20728409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis and Annotation of Whole-Genome or Whole-Exome Sequencing Derived Variants for Clinical Diagnosis.
    Worthey EA
    Curr Protoc Hum Genet; 2017 Oct; 95():9.24.1-9.24.28. PubMed ID: 29044471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement of Plant Productivity in the Post-Genomics Era.
    Thao NP; Tran LS
    Curr Genomics; 2016 Aug; 17(4):295-6. PubMed ID: 27499678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diverse type 2 diabetes genetic risk factors functionally converge in a phenotype-focused gene network.
    Sandor C; Beer NL; Webber C
    PLoS Comput Biol; 2017 Oct; 13(10):e1005816. PubMed ID: 29059180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.